US Stock MarketDetailed Quotes

BMEZ Blackrock Health Sciences Trust II

Watchlist

15.590
-0.330-2.07%

Close Jul 18 16:00 ET

1.66BMarket Cap21.36P/E (TTM)

Blackrock Health Sciences Trust II Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q2)Jun 30, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q2)Jun 30, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q2)Jun 30, 2021

(FY)Dec 31, 2020

Assets

Cash cash equivalents and federal funds sold

1,165.87%457.17K

-69.79%37.1K

-76.83%36.12K

-90.03%122.81K

-87.67%155.88K

--155.88K

-65.91%1.23M

--1.26M

-Cash and cash equivalents

915.65%1.17K

-98.74%1.1K

-99.90%115

12,126.76%86.81K

11,828.66%119.88K

--119.88K

-99.66%710

--1.01K

-Restricted cash and investments

1,166.67%456K

0.00%36K

-97.08%36K

-97.15%36K

--36K

-63.80%1.23M

--1.26M

Receivables

46.84%1.48M

1,349.83%17.87M

-34.01%1.01M

-75.69%1.23M

18.44%1.53M

--1.53M

-62.01%5.07M

--1.29M

Prepaid assets

--16.16K

----

--0

139.26%48.37K

--48.37K

----

--20.22K

Derivative assets

-71.21%1.43M

--963.12K

--4.96M

----

Deferred costs

--0

Total assets

-6.32%1.95B

0.12%2.15B

-30.89%2.09B

-38.18%2.15B

-14.84%3.02B

--3.02B

29.19%3.48B

--3.54B

Liabilities

Payables

-70.32%2.61M

527.39%37.16M

8.51%8.79M

-29.42%5.92M

-62.61%8.1M

--8.1M

49.32%8.39M

--21.66M

-Accounts payable

----

882.03%30.54M

-37.23%2.9M

-5.26%3.11M

-74.39%4.62M

--4.62M

36.25%3.28M

--18.04M

-Other payable

-55.69%2.61M

135.24%6.62M

69.30%5.89M

-44.94%2.81M

-3.77%3.48M

--3.48M

59.13%5.11M

--3.61M

Long term debt and capital lease obligation

206.23%291.88K

----

--95.31K

-95.52%69.8K

----

--1.56M

--205.46K

Derivative product liabilities

69.94%31.43M

2.23%20.15M

-20.09%18.5M

-46.54%19.71M

-53.47%23.15M

--23.15M

-4.07%36.88M

--49.75M

Other liabilities

572.17%12.3M

467.74%38.94M

-62.96%1.83M

9.82%6.86M

-48.42%4.94M

--4.94M

230.49%6.25M

--9.58M

Total liabilities

58.83%46.7M

193.66%96.35M

-19.19%29.4M

-38.98%32.81M

-55.43%36.38M

--36.38M

16.13%53.77M

--81.64M

Shareholders'equity

Share capital

-10.41%1.95B

-4.08%2.15B

-3.36%2.18B

-0.42%2.24B

0.00%2.25B

--2.25B

0.00%2.25B

--2.25B

-common stock

-10.41%1.95B

-4.08%2.15B

-3.36%2.18B

-0.42%2.24B

0.00%2.25B

--2.25B

0.00%2.25B

--2.25B

Retained earnings

63.99%-43.69M

24.71%-93.6M

-116.65%-121.32M

-110.58%-124.32M

-39.76%728.49M

--728.49M

197.03%1.17B

--1.21B

Total stockholders'equity

-7.25%1.91B

-2.88%2.06B

-31.04%2.06B

-38.17%2.12B

-13.88%2.98B

--2.98B

29.42%3.43B

--3.46B

Total equity

-7.25%1.91B

-2.88%2.06B

-31.04%2.06B

-38.17%2.12B

-13.88%2.98B

--2.98B

29.42%3.43B

--3.46B

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q2)Jun 30, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q2)Jun 30, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q2)Jun 30, 2021	(FY)Dec 31, 2020
Assets
Cash cash equivalents and federal funds sold	1,165.87%457.17K	1,165.87%457.17K	-69.79%37.1K	-76.83%36.12K	-76.83%36.12K	-90.03%122.81K	-87.67%155.88K	--155.88K	-65.91%1.23M	--1.26M
-Cash and cash equivalents	915.65%1.17K	915.65%1.17K	-98.74%1.1K	-99.90%115	-99.90%115	12,126.76%86.81K	11,828.66%119.88K	--119.88K	-99.66%710	--1.01K
-Restricted cash and investments	1,166.67%456K	1,166.67%456K	0.00%36K	0.00%36K	0.00%36K	-97.08%36K	-97.15%36K	--36K	-63.80%1.23M	--1.26M
Receivables	46.84%1.48M	46.84%1.48M	1,349.83%17.87M	-34.01%1.01M	-34.01%1.01M	-75.69%1.23M	18.44%1.53M	--1.53M	-62.01%5.07M	--1.29M
Prepaid assets	--16.16K	--16.16K	----	----	----	--0	139.26%48.37K	--48.37K	----	--20.22K
Derivative assets	-71.21%1.43M	-71.21%1.43M	--963.12K	--4.96M	--4.96M	----	----	----	----	----
Deferred costs	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total assets	-6.32%1.95B	-6.32%1.95B	0.12%2.15B	-30.89%2.09B	-30.89%2.09B	-38.18%2.15B	-14.84%3.02B	--3.02B	29.19%3.48B	--3.54B
Liabilities
Payables	-70.32%2.61M	-70.32%2.61M	527.39%37.16M	8.51%8.79M	8.51%8.79M	-29.42%5.92M	-62.61%8.1M	--8.1M	49.32%8.39M	--21.66M
-Accounts payable	----	----	882.03%30.54M	-37.23%2.9M	-37.23%2.9M	-5.26%3.11M	-74.39%4.62M	--4.62M	36.25%3.28M	--18.04M
-Other payable	-55.69%2.61M	-55.69%2.61M	135.24%6.62M	69.30%5.89M	69.30%5.89M	-44.94%2.81M	-3.77%3.48M	--3.48M	59.13%5.11M	--3.61M
Long term debt and capital lease obligation	206.23%291.88K	206.23%291.88K	----	--95.31K	--95.31K	-95.52%69.8K	----	----	--1.56M	--205.46K
Derivative product liabilities	69.94%31.43M	69.94%31.43M	2.23%20.15M	-20.09%18.5M	-20.09%18.5M	-46.54%19.71M	-53.47%23.15M	--23.15M	-4.07%36.88M	--49.75M
Other liabilities	572.17%12.3M	572.17%12.3M	467.74%38.94M	-62.96%1.83M	-62.96%1.83M	9.82%6.86M	-48.42%4.94M	--4.94M	230.49%6.25M	--9.58M
Total liabilities	58.83%46.7M	58.83%46.7M	193.66%96.35M	-19.19%29.4M	-19.19%29.4M	-38.98%32.81M	-55.43%36.38M	--36.38M	16.13%53.77M	--81.64M
Shareholders'equity
Share capital	-10.41%1.95B	-10.41%1.95B	-4.08%2.15B	-3.36%2.18B	-3.36%2.18B	-0.42%2.24B	0.00%2.25B	--2.25B	0.00%2.25B	--2.25B
-common stock	-10.41%1.95B	-10.41%1.95B	-4.08%2.15B	-3.36%2.18B	-3.36%2.18B	-0.42%2.24B	0.00%2.25B	--2.25B	0.00%2.25B	--2.25B
Retained earnings	63.99%-43.69M	63.99%-43.69M	24.71%-93.6M	-116.65%-121.32M	-116.65%-121.32M	-110.58%-124.32M	-39.76%728.49M	--728.49M	197.03%1.17B	--1.21B
Total stockholders'equity	-7.25%1.91B	-7.25%1.91B	-2.88%2.06B	-31.04%2.06B	-31.04%2.06B	-38.17%2.12B	-13.88%2.98B	--2.98B	29.42%3.43B	--3.46B
Total equity	-7.25%1.91B	-7.25%1.91B	-2.88%2.06B	-31.04%2.06B	-31.04%2.06B	-38.17%2.12B	-13.88%2.98B	--2.98B	29.42%3.43B	--3.46B
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion	--	--	Unqualified Opinion	--	--	Unqualified Opinion	--	--	Unqualified Opinion

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall